CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney...
Phase 3
Roma, Italy and 319 other locations
We are doing this study to learn more about how semaglutide may help fight chronic kidney disease in people with type 2 diabetes. W...
Phase 3
Roma, Italy and 32 other locations
to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney...
Phase 3
Roma, Italy and 295 other locations
The study evaluates the safety of different doses of a new medicine called NNC0519 0130. It also looks into how the medicine may improve kidney...
Phase 2
Roma, Italy and 100 other locations
Researchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD). The trial ...
Phase 3
Roma, Lazio, Italy and 338 other locations
Researchers are looking for a better way to treat people with chronic kidney disease (CKD), a progressive decrease in the kidneys...
Phase 3
Roma, Lazio, Italy and 84 other locations
Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...
Phase 3
Roma, Lazio, Italy and 145 other locations
Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...
Phase 3
Roma, Lazio, Italy and 129 other locations
of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/ ...
Phase 3
Rome, Roma, Italy and 744 other locations
(for example heart attack and stroke) in people with cardiovascular disease, chronic kidney disease and inflammation.Parti...
Phase 3
Rome, Italy and 950 other locations
Clinical trials
Research sites
Resources
Legal